selected publications
- 18F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2024 Academic Article GET IT
- Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2024 Academic Article GET IT
- First-in-Human Evaluation of Site-Specifically Labeled 89Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2024 Academic Article GET IT
- First-in-human imaging with [ 89 Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate. 2024 GET IT
- Correction to "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model". 2024 GET IT
- Methods for the Production of Radiolabeled Bioagents for ImmunoPET. Methods in molecular biology (Clifton, N.J.). 2024 Review GET IT
- Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model. ACS pharmacology & translational science. 2023 Academic Article GET IT
- Development of immunoliposomes containing cytotoxic gold payloads against HER2-positive breast cancers. RSC medicinal chemistry. 2023 Academic Article GET IT
- 212Pb-Pretargeted Theranostics for Pancreatic Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2023 Academic Article GET IT
- Click Chemistry and Radiochemistry: An Update. Bioconjugate chemistry. 2023 Review GET IT
- PET and Optical Imaging of Caveolin-1 in Gastric Tumors. ACS omega. 2023 Academic Article GET IT
- Ambient Light Resistant Shortwave Infrared Fluorescence Imaging for Preclinical Tumor Delineation via the pH Low-Insertion Peptide Conjugated to Indocyanine Green. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2023 Academic Article GET IT
- Determinants of survival in HER2+ metastatic esophagogastric cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2023 Academic Article GET IT
- Immuno-PET Detects Antibody-Drug Potency on Coadministration with Statins. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2023 Academic Article GET IT
-
Development and Validation of Nerve-Targeted Bacteriochlorin Sensors.
Journal of the American Chemical Society.
2023
Academic Article
GET IT
Times cited: 1 - Click chemistry: a transformative technology in nuclear medicine. Nature protocols. 2023 Review GET IT
-
89Zr-DFO-Isatuximab for CD38-Targeted ImmunoPET Imaging of Multiple Myeloma and Lymphomas.
ACS omega.
2023
Academic Article
GET IT
Times cited: 2 -
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer.
Nature cancer.
2023
Academic Article
GET IT
Times cited: 212 - Statins enhance the efficacy of HER2-targeting radioligand therapy in drug-resistant gastric cancers. Proceedings of the National Academy of Sciences of the United States of America. 2023 Academic Article GET IT
-
Sc-HOPO: A Potential Construct for Use in Radioscandium-Based Radiopharmaceuticals.
Inorganic chemistry.
2023
Academic Article
GET IT
Times cited: 4 - Radiances of Cerenkov-Emitting Isotopes on the IVIS. 2023 GET IT
-
Click Here for Better Chemistry.
The New England journal of medicine.
2022
Academic Article
GET IT
Times cited: 5 -
Noninvasive Assessment of Human Epidermal Growth Factor Receptor 2 (HER2) in Esophagogastric Cancer Using 89Zr-Trastuzumab PET: A Pilot Study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2022
Academic Article
GET IT
Times cited: 5 - Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies. Journal of hematology & oncology. 2022 Academic Article GET IT
- Refined Chelator Spacer Moieties Ameliorate the Pharmacokinetics of PSMA-617. Frontiers in chemistry. 2022 Academic Article GET IT
-
Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer.
Proceedings of the National Academy of Sciences of the United States of America.
2022
Academic Article
GET IT
Times cited: 13 -
Radiotheranostics in oncology: current challenges and emerging opportunities.
Nature reviews. Clinical oncology.
2022
Review
GET IT
Times cited: 43 -
Pretargeted PET of Osteodestructive Lesions in Dogs.
Molecular pharmaceutics.
2022
Academic Article
GET IT
Times cited: 8 -
PET Imaging of Acidic Tumor Environment With 89Zr-labeled pHLIP Probes.
Frontiers in oncology.
2022
Academic Article
GET IT
Times cited: 8 -
Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer.
Nature communications.
2022
Academic Article
GET IT
Times cited: 9 -
Noninvasive Imaging of CD4+ T Cells in Humanized Mice.
Molecular cancer therapeutics.
2022
Academic Article
GET IT
Times cited: 3 -
Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2022
Academic Article
GET IT
Times cited: 16 -
ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2022
Academic Article
GET IT
Times cited: 11 -
EGFR-Targeted ImmunoPET of UMUC3 Orthotopic Bladder Tumors.
Molecular imaging and biology.
2022
Academic Article
GET IT
Times cited: 5 -
Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2022
Academic Article
GET IT
Times cited: 16 -
Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2021
Academic Article
GET IT
Times cited: 6 -
Novel Tracers and Radionuclides in PET Imaging.
Radiologic clinics of North America.
2021
Review
GET IT
Times cited: 3 - Influence of Fc Modifications and IgG Subclass on Biodistribution of Humanized Antibodies Targeting L1CAM. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2021 Academic Article GET IT
-
ERK Inhibition Improves Anti-PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma.
Molecular cancer therapeutics.
2021
Academic Article
GET IT
Times cited: 7 -
Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system.
Nature communications.
2021
Academic Article
GET IT
Times cited: 18 - State-of-the-Art of Radiometal-based Bioconjugates for Molecular Imaging and Radiotherapy. Bioconjugate chemistry. 2021 Editorial Article GET IT
-
Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity.
Cancer cell.
2021
Academic Article
GET IT
Times cited: 1 -
Recent Advances in Radiometals for Combined Imaging and Therapy in Cancer.
ChemMedChem.
2021
Review
GET IT
Times cited: 32 - Reply: Potential Use of Radiolabeled Antibodies for Imaging and Treatment of COVID-19. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2021 Letter GET IT
-
Synthesis and Comparative In Vivo Evaluation of Site-Specifically Labeled Radioimmunoconjugates for DLL3-Targeted ImmunoPET.
Bioconjugate chemistry.
2021
Academic Article
GET IT
Times cited: 5 - Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2021 Academic Article GET IT
-
Technical Note: Patient-morphed mesh-type phantoms to support personalized nuclear medicine dosimetry - a proof of concept study.
Medical physics.
2021
Academic Article
GET IT
Times cited: 2 -
Medical imaging and nuclear medicine: a Lancet Oncology Commission.
The Lancet. Oncology.
2021
Information Resource
GET IT
Times cited: 14 -
Applications of nuclear-based imaging in gene and cell therapy: probe considerations.
Molecular therapy oncolytics.
2021
Academic Article
GET IT
Times cited: 9 -
A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals.
European journal of nuclear medicine and molecular imaging.
2021
Academic Article
GET IT
Times cited: 6 -
Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [64Cu]Cu-NOTA-anti-CD8 PET.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2021
Academic Article
GET IT
Times cited: 23 -
Bimodal Imaging of Mouse Peripheral Nerves with Chlorin Tracers.
Molecular pharmaceutics.
2021
Academic Article
GET IT
Times cited: 4 -
Predicting CAR-T cell Immunotherapy Success through ImmunoPET.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2020
Comment
GET IT
Times cited: 5 -
Polyazamacrocycle Ligands Facilitate 89Zr Radiochemistry and Yield 89Zr Complexes with Remarkable Stability.
Inorganic chemistry.
2020
Academic Article
GET IT
Times cited: 12 -
Imaging Early-Stage Metastases Using an 18F-Labeled VEGFR-1-Specific Single Chain VEGF Mutant.
Molecular imaging and biology.
2020
Academic Article
GET IT
Times cited: 6 -
Comparison of Methods for Surface Modification of Barium Titanate Nanoparticles for Aqueous Dispersibility: Toward Biomedical Utilization of Perovskite Oxides.
ACS applied materials & interfaces.
2020
Academic Article
GET IT
Times cited: 15 -
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2020
Academic Article
GET IT
Times cited: 37 -
pHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgery.
Scientific reports.
2020
Academic Article
GET IT
Times cited: 18 -
Harnessing 64Cu/67Cu for a theranostic approach to pretargeted radioimmunotherapy.
Proceedings of the National Academy of Sciences of the United States of America.
2020
Academic Article
GET IT
Times cited: 60 -
Leveraging synthetic chlorins for bio-imaging applications.
Chemical communications (Cambridge, England).
2020
Academic Article
GET IT
Times cited: 7 -
Antibody-Targeted Imaging of Gastric Cancer.
Molecules (Basel, Switzerland).
2020
Review
GET IT
Times cited: 7 -
Aromatic carbohydrate amphiphile disrupts cancer spheroids and prevents relapse.
Nanoscale.
2020
Academic Article
GET IT
Times cited: 8 -
Acute Statin Treatment Improves Antibody Accumulation in EGFR- and PSMA-Expressing Tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2020
Academic Article
GET IT
Times cited: 17 -
ImmunoPET Imaging of Pancreatic Tumors with 89Zr-Labeled Gold Nanoparticle-Antibody Conjugates.
Molecular imaging and biology.
2020
Academic Article
GET IT
Times cited: 15 -
A High-Denticity Chelator Based on Desferrioxamine for Enhanced Coordination of Zirconium-89.
Inorganic chemistry.
2020
Academic Article
GET IT
Times cited: 19 -
Head-to-Head Evaluation of 18F-FES and 18F-FDG PET/CT in Metastatic Invasive Lobular Breast Cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2020
Academic Article
GET IT
Times cited: 64 -
Oncology-Inspired Treatment Options for COVID-19.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2020
Academic Article
GET IT
Times cited: 13 -
A Molecularly Targeted Intraoperative Near-Infrared Fluorescence Imaging Agent for High-Grade Serous Ovarian Cancer.
Molecular pharmaceutics.
2020
Academic Article
GET IT
Times cited: 12 -
Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2020
Academic Article
GET IT
Times cited: 3 -
Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted 89Zr-Pertuzumab PET/CT.
Radiology.
2020
Academic Article
GET IT
Times cited: 38 -
Fluorescence labeling of a NaV1.7-targeted peptide for near-infrared nerve visualization.
EJNMMI research.
2020
Academic Article
GET IT
Times cited: 12 -
Comparison of 68Ga-DOTA-JR11 PET/CT with dosimetric 177Lu-satoreotide tetraxetan (177Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy.
European journal of nuclear medicine and molecular imaging.
2020
Academic Article
GET IT
Times cited: 16 -
First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2020
Academic Article
GET IT
Times cited: 14 - Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation. Nuclear medicine and biology. 2020 Academic Article GET IT
-
89Zr-PET imaging of DNA double-strand breaks for the early monitoring of response following α- and β-particle radioimmunotherapy in a mouse model of pancreatic ductal adenocarcinoma.
Theranostics.
2020
Academic Article
GET IT
Times cited: 13 - Inhibiting cancer metabolism by aromatic carbohydrate amphiphiles that act as antagonists of the glucose transporter GLUT1. Chemical Science. 2020 Article GET IT
-
3D-Printable Platform for High-Throughput Small-Animal Imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2020
Letter
GET IT
Times cited: 4 -
CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging.
Radiology.
2020
Academic Article
GET IT
Times cited: 71 -
pH-Responsive Polymers for Improving the Signal-to-Noise Ratio of Hypoxia PET Imaging with [18 F]Fluoromisonidazole.
Macromolecular rapid communications.
2020
Academic Article
GET IT
Times cited: 4 -
Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2020
Academic Article
GET IT
Times cited: 36 -
A Systematic Evaluation of Antibody Modification and 89Zr-Radiolabeling for Optimized Immuno-PET.
Bioconjugate chemistry.
2020
Academic Article
GET IT
Times cited: 21 -
HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers.
Cancer discovery.
2020
Academic Article
GET IT
Times cited: 136 -
Inhibiting cancer metabolism by aromatic carbohydrate amphiphiles that act as antagonists of the glucose transporter GLUT1.
Chemical science.
2020
Academic Article
GET IT
Times cited: 20 -
First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2020
Academic Article
GET IT
Times cited: 4 -
Radiotheranostics: a roadmap for future development.
The Lancet. Oncology.
2020
Review
GET IT
Times cited: 136 -
Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissue.
Nuclear medicine and biology.
2020
Academic Article
GET IT
Times cited: 14 -
Manipulating the In Vivo Behaviour of 68Ga with Tris(Hydroxypyridinone) Chelators: Pretargeting and Blood Clearance.
International journal of molecular sciences.
2020
Academic Article
GET IT
Times cited: 9 -
iNOS Regulates the Therapeutic Response of Pancreatic Cancer Cells to Radiotherapy.
Cancer research.
2020
Academic Article
GET IT
Times cited: 31 -
Targeted Brain Tumor Radiotherapy Using an Auger Emitter.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2020
Academic Article
GET IT
Times cited: 67 - Changing of the Guard at Molecular Imaging & Biology. Molecular imaging and biology. 2020 Editorial Article GET IT
- Correction to: The 2019 World Molecular Imaging Congress (WMIC) and Molecular Imaging and Biology (MIB) Awards. 2020 GET IT
- The 2019 World Molecular Imaging Congress (WMIC) and Molecular Imaging and Biology (MIB) Awards. Molecular imaging and biology. 2020 Editorial Article GET IT
-
The Impact of Positron Range on PET Resolution, Evaluated with Phantoms and PHITS Monte Carlo Simulations for Conventional and Non-conventional Radionuclides.
Molecular imaging and biology.
2020
Academic Article
GET IT
Times cited: 45 -
Demarcation of Sepsis-Induced Peripheral and Central Acidosis with pH (Low) Insertion Cycle Peptide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2020
Academic Article
GET IT
Times cited: 11 -
PET/CT Imaging with an 18F-Labeled Galactodendritic Unit in a Galectin-1-Overexpressing Orthotopic Bladder Cancer Model.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2020
Academic Article
GET IT
Times cited: 4 -
Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effect.
Theranostics.
2020
Academic Article
GET IT
Times cited: 64 -
ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors.
Theranostics.
2020
Academic Article
GET IT
Times cited: 19 -
The Influence of Glycans-Specific Bioconjugation on the FcγRI Binding and In vivo Performance of 89Zr-DFO-Pertuzumab.
Theranostics.
2020
Academic Article
GET IT
Times cited: 31 -
HER2-Targeted PET Imaging and Therapy of Hyaluronan-Masked HER2-Overexpressing Breast Cancer.
Molecular pharmaceutics.
2019
Academic Article
GET IT
Times cited: 20 -
Multimodality labeling strategies for the investigation of nanocrystalline cellulose biodistribution in a mouse model of breast cancer.
Nuclear medicine and biology.
2019
Academic Article
GET IT
Times cited: 12 -
Paradigms for Precision Medicine in Epichaperome Cancer Therapy.
Cancer cell.
2019
Academic Article
GET IT
Times cited: 38 -
First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2019
Academic Article
GET IT
Times cited: 151 -
Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2019
Academic Article
GET IT
Times cited: 43 -
Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2019
Academic Article
GET IT
Times cited: 60 -
An 89Zr-HDL PET Tracer Monitors Response to a CSF1R Inhibitor.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2019
Academic Article
GET IT
Times cited: 24 -
Biodistribution and Dosimetry of Intraventricularly Administered 124I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2019
Academic Article
GET IT
Times cited: 28 -
Improved synthesis of the bifunctional chelator p-SCN-Bn-HOPO.
Organic & biomolecular chemistry.
2019
Academic Article
GET IT
Times cited: 11 -
PARaDIM: A PHITS-Based Monte Carlo Tool for Internal Dosimetry with Tetrahedral Mesh Computational Phantoms.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2019
Academic Article
GET IT
Times cited: 23 -
Acid specific dark quencher QC1 pHLIP for multi-spectral optoacoustic diagnoses of breast cancer.
Scientific reports.
2019
Academic Article
GET IT
Times cited: 15 -
Multimodal Positron Emission Tomography Imaging to Quantify Uptake of 89Zr-Labeled Liposomes in the Atherosclerotic Vessel Wall.
Bioconjugate chemistry.
2019
Academic Article
GET IT
Times cited: 21 -
Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2019
Academic Article
GET IT
Times cited: 25 -
A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals.
Nuclear medicine and biology.
2019
Academic Article
GET IT
Times cited: 30 -
Toward the Optimization of Click-Mediated Pretargeted Radioimmunotherapy.
Molecular pharmaceutics.
2019
Academic Article
GET IT
Times cited: 19 - A Conversation Between Michael Phelps and Jason Lewis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2019 Article GET IT
-
Assessment of Simplified Methods for Quantification of 18F-FDHT Uptake in Patients with Metastatic Castration-Resistant Prostate Cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2019
Academic Article
GET IT
Times cited: 10 -
Trastuzumab gold-conjugates: synthetic approach and in vitro evaluation of anticancer activities in breast cancer cell lines.
Chemical communications (Cambridge, England).
2019
Academic Article
GET IT
Times cited: 21 -
Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacy.
Nature communications.
2018
Academic Article
GET IT
Times cited: 78 -
EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer.
Cancer discovery.
2018
Academic Article
GET IT
Times cited: 113 -
Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors.
European journal of nuclear medicine and molecular imaging.
2018
Academic Article
GET IT
Times cited: 39 - Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
-
Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis.
JACC. Cardiovascular imaging.
2018
Academic Article
GET IT
Times cited: 64 -
Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model.
Molecular imaging and biology.
2018
Academic Article
GET IT
Times cited: 21 -
Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2018
Academic Article
GET IT
Times cited: 18 -
A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2018
Academic Article
GET IT
Times cited: 10 -
Leveraging PET to image folate receptor α therapy of an antibody-drug conjugate.
EJNMMI research.
2018
Academic Article
GET IT
Times cited: 12 -
Clinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging in Breast Cancer.
PET clinics.
2018
Information Resource
GET IT
Times cited: 20 -
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.
The Lancet. Oncology.
2018
Academic Article
GET IT
Times cited: 184 -
Imaging EGFR and HER3 through 89Zr-labeled MEHD7945A (Duligotuzumab).
Scientific reports.
2018
Academic Article
GET IT
Times cited: 16 -
Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer.
Nature communications.
2018
Academic Article
GET IT
Times cited: 33 -
Imaging of human epidermal growth factor receptors for patient selection and response monitoring - From PET imaging and beyond.
Cancer letters.
2018
Information Resource
GET IT
Times cited: 19 -
Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2018
Academic Article
GET IT
Times cited: 18 -
Preclinical optimization of antibody-based radiopharmaceuticals for cancer imaging and radionuclide therapy-Model, vector, and radionuclide selection.
Journal of labelled compounds & radiopharmaceuticals.
2018
Information Resource
GET IT
Times cited: 23 -
PARP-1-Targeted Radiotherapy in Mouse Models of Glioblastoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2018
Academic Article
GET IT
Times cited: 48 -
Click-Mediated Pretargeted Radioimmunotherapy of Colorectal Carcinoma.
Molecular pharmaceutics.
2018
Academic Article
GET IT
Times cited: 36 -
The inverse electron-demand Diels-Alder reaction as a new methodology for the synthesis of 225Ac-labelled radioimmunoconjugates.
Chemical communications (Cambridge, England).
2018
Academic Article
GET IT
Times cited: 31 -
Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran Polymers.
Bioconjugate chemistry.
2018
Academic Article
GET IT
Times cited: 36 -
Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer.
JAMA oncology.
2018
Academic Article
GET IT
Times cited: 80 -
In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of 18F-(2S,4R)-4-Fluoroglutamine.
Radiology.
2018
Academic Article
GET IT
Times cited: 75 -
Fc-Mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models.
Cancer research.
2018
Academic Article
GET IT
Times cited: 65 -
Pretargeting of internalizing trastuzumab and cetuximab with a 18F-tetrazine tracer in xenograft models.
EJNMMI research.
2017
Academic Article
GET IT
Times cited: 60 -
89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer.
Clinical nuclear medicine.
2017
Academic Article
GET IT
Times cited: 82 -
Current status and future challenges for molecular imaging.
Philosophical transactions. Series A, Mathematical, physical, and engineering sciences.
2017
Information Resource
GET IT
Times cited: 7 -
First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using 89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2017
Academic Article
GET IT
Times cited: 118 -
A phase II study of radioimmunotherapy with intraventricular 131 I-3F8 for medulloblastoma.
Pediatric blood & cancer.
2017
Academic Article
GET IT
Times cited: 45 -
Exploring Structural Parameters for Pretargeting Radioligand Optimization.
Journal of medicinal chemistry.
2017
Academic Article
GET IT
Times cited: 48 -
Multiplexed imaging for diagnosis and therapy.
Nature biomedical engineering.
2017
Review
GET IT
Times cited: 121 -
Noninvasive 89Zr-Transferrin PET Shows Improved Tumor Targeting Compared with 18F-FDG PET in MYC-Overexpressing Human Triple-Negative Breast Cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2017
Academic Article
GET IT
Times cited: 27 -
Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphoma.
Proceedings of the National Academy of Sciences of the United States of America.
2017
Academic Article
GET IT
Times cited: 24 -
Long-Half-Life 89Zr-Labeled Radiotracers Can Guide Percutaneous Biopsy Within the PET/CT Suite Without Reinjection of Radiotracer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2017
Academic Article
GET IT
Times cited: 9 -
Biodistribution and Dosimetry of 18F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2017
Academic Article
GET IT
Times cited: 86 -
Human Epidermal Growth Factor Receptor 2-Targeted PET/Single- Photon Emission Computed Tomography Imaging of Breast Cancer: Noninvasive Measurement of a Biomarker Integral to Tumor Treatment and Prognosis.
PET clinics.
2017
Information Resource
GET IT
Times cited: 46 -
Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth.
ACS chemical biology.
2017
Academic Article
GET IT
Times cited: 31 -
Pharmacokinetics, Biodistribution, and Radiation Dosimetry for 89Zr-Trastuzumab in Patients with Esophagogastric Cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2017
Academic Article
GET IT
Times cited: 92 -
Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer.
Cancer research.
2017
Academic Article
GET IT
Times cited: 78 -
Applications of pHLIP Technology for Cancer Imaging and Therapy.
Trends in biotechnology.
2017
Information Resource
GET IT
Times cited: 82 -
Multinuclear NMR and MRI Reveal an Early Metabolic Response to mTOR Inhibition in Sarcoma.
Cancer research.
2017
Academic Article
GET IT
Times cited: 17 -
89Zr-DFO-AMG102 Immuno-PET to Determine Local Hepatocyte Growth Factor Protein Levels in Tumors for Enhanced Patient Selection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2017
Academic Article
GET IT
Times cited: 30 -
Preloading with Unlabeled CA19.9 Targeted Human Monoclonal Antibody Leads to Improved PET Imaging with 89Zr-5B1.
Molecular pharmaceutics.
2017
Academic Article
GET IT
Times cited: 30 -
Noninvasive Measurement of mTORC1 Signaling with 89Zr-Transferrin.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2016
Academic Article
GET IT
Times cited: 17 -
Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axis.
Science translational medicine.
2016
Academic Article
GET IT
Times cited: 18 -
Click Chemistry and Radiochemistry: The First 10 Years.
Bioconjugate chemistry.
2016
Information Resource
GET IT
Times cited: 181 -
Prospective Clinical Trial of 18F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in Invasive Ductal and Invasive Lobular Breast Cancers.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2016
Academic Article
GET IT
Times cited: 45 -
Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry.
Molecular cancer therapeutics.
2016
Academic Article
GET IT
Times cited: 77 -
Imaging biomarker roadmap for cancer studies.
Nature reviews. Clinical oncology.
2016
Conference Paper
GET IT
Times cited: 732 -
The epichaperome is an integrated chaperome network that facilitates tumour survival.
Nature.
2016
Academic Article
GET IT
Times cited: 187 -
A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer.
Theranostics.
2016
Academic Article
GET IT
Times cited: 50 -
First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2016
Academic Article
GET IT
Times cited: 99 -
PET Imaging of Extracellular pH in Tumors with (64)Cu- and (18)F-Labeled pHLIP Peptides: A Structure-Activity Optimization Study.
Bioconjugate chemistry.
2016
Academic Article
GET IT
Times cited: 51 -
Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate.
Bioconjugate chemistry.
2016
Academic Article
GET IT
Times cited: 58 -
Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2016
Academic Article
GET IT
Times cited: 21 -
Fully automated synthesis of [(18) F]fluoro-dihydrotestosterone ([(18) F]FDHT) using the FlexLab module.
Journal of labelled compounds & radiopharmaceuticals.
2016
Academic Article
GET IT
Times cited: 10 -
A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)Y.
Nuclear medicine and biology.
2016
Academic Article
GET IT
Times cited: 25 -
Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.
Nature communications.
2016
Academic Article
GET IT
Times cited: 94 -
In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.
JACC. Cardiovascular imaging.
2016
Academic Article
GET IT
Times cited: 79 -
Synthesis and evaluation of an (18)F-labeled pyrimidine-pyridine amine for targeting CXCR4 receptors in gliomas.
Nuclear medicine and biology.
2016
Academic Article
GET IT
Times cited: 12 -
Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2016
Academic Article
GET IT
Times cited: 141 -
Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2016
Academic Article
GET IT
Times cited: 32 -
Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2016
Academic Article
GET IT
Times cited: 31 -
Radiosynthesis of the iodine-124 labeled Hsp90 inhibitor PU-H71.
Journal of labelled compounds & radiopharmaceuticals.
2016
Academic Article
GET IT
Times cited: 16 -
Applying ⁸⁹Zr-Transferrin To Study the Pharmacology of Inhibitors to BET Bromodomain Containing Proteins.
Molecular pharmaceutics.
2016
Academic Article
GET IT
Times cited: 12 -
Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer.
Proceedings of the National Academy of Sciences of the United States of America.
2015
Academic Article
GET IT
Times cited: 80 -
p-SCN-Bn-HOPO: A Superior Bifunctional Chelator for (89)Zr ImmunoPET.
Bioconjugate chemistry.
2015
Academic Article
GET IT
Times cited: 101 -
(18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click Chemistry.
Bioconjugate chemistry.
2015
Academic Article
GET IT
Times cited: 126 -
Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2015
Academic Article
GET IT
Times cited: 76 -
Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation.
Cancer research.
2015
Academic Article
GET IT
Times cited: 102 -
Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.
Molecular pharmaceutics.
2015
Academic Article
GET IT
Times cited: 86 - Precision Medicine…Visualized-a Message from the President of the WMIC. Molecular imaging and biology. 2015 Editorial Article GET IT
-
A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2015
Academic Article
GET IT
Times cited: 159 -
PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2015
Academic Article
GET IT
Times cited: 141 -
Fully-automated synthesis of 16β-(18)F-fluoro-5α-dihydrotestosterone (FDHT) on the ELIXYS radiosynthesizer.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
2015
Academic Article
GET IT
Times cited: 8 -
Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy.
Journal of neuro-oncology.
2015
Academic Article
GET IT
Times cited: 22 -
Challenges of Pancreatic Cancer.
Cancer journal (Sudbury, Mass.).
2015
Information Resource
GET IT
Times cited: 41 -
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer.
Science translational medicine.
2015
Academic Article
GET IT
Times cited: 256 -
Evaluation of hypoxia with copper-labeled diacetyl-bis(N-methylthiosemicarbazone).
Seminars in nuclear medicine.
2015
Information Resource
GET IT
Times cited: 34 -
The bioconjugation and radiosynthesis of 89Zr-DFO-labeled antibodies.
Journal of visualized experiments : JoVE.
2015
Academic Article
GET IT
Times cited: 73 -
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo.
Science translational medicine.
2015
Academic Article
GET IT
Times cited: 241 -
Harnessing the bioorthogonal inverse electron demand Diels-Alder cycloaddition for pretargeted PET imaging.
Journal of visualized experiments : JoVE.
2015
Academic Article
GET IT
Times cited: 7 -
Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging.
Bioconjugate chemistry.
2014
Academic Article
GET IT
Times cited: 64 -
Annotating STEAP1 regulation in prostate cancer with 89Zr immuno-PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2014
Academic Article
GET IT
Times cited: 24 -
Synthesis and evaluation of (18)F-labeled ATP competitive inhibitors of topoisomerase II as probes for imaging topoisomerase II expression.
European journal of medicinal chemistry.
2014
Academic Article
GET IT
Times cited: 10 -
What a difference a carbon makes: H₄octapa vs H₄C3octapa, ligands for In-111 and Lu-177 radiochemistry.
Inorganic chemistry.
2014
Academic Article
GET IT
Times cited: 35 -
⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer.
European journal of nuclear medicine and molecular imaging.
2014
Academic Article
GET IT
Times cited: 123 -
CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma.
Genes & development.
2014
Academic Article
GET IT
Times cited: 154 -
A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2014
Academic Article
GET IT
Times cited: 81 -
Targeting breast tumors with pH (low) insertion peptides.
Molecular pharmaceutics.
2014
Academic Article
GET IT
Times cited: 53 -
In vivo imaging of GLP-1R with a targeted bimodal PET/fluorescence imaging agent.
Bioconjugate chemistry.
2014
Academic Article
GET IT
Times cited: 47 -
Development of a minimal saponin vaccine adjuvant based on QS-21.
Nature chemistry.
2014
Academic Article
GET IT
Times cited: 72 -
Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).
Journal of medicinal chemistry.
2014
Academic Article
GET IT
Times cited: 139 -
Noninvasive Imaging of PSMA in prostate tumors with (89)Zr-Labeled huJ591 engineered antibody fragments: the faster alternatives.
Molecular pharmaceutics.
2014
Academic Article
GET IT
Times cited: 65 -
Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer.
Proceedings of the National Academy of Sciences of the United States of America.
2014
Academic Article
GET IT
Times cited: 39 -
Building Blocks for the Construction of Bioorthogonally Reactive Peptides via Solid-Phase Peptide Synthesis.
ChemistryOpen.
2014
Academic Article
GET IT
Times cited: 24 -
Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer.
Science signaling.
2014
Academic Article
GET IT
Times cited: 115 -
Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcinoma.
European journal of nuclear medicine and molecular imaging.
2014
Academic Article
GET IT
Times cited: 63 -
Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2014
Academic Article
GET IT
Times cited: 60 -
H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu.
Dalton transactions (Cambridge, England : 2003).
2014
Academic Article
GET IT
Times cited: 55 -
Influence of free fatty acids on glucose uptake in prostate cancer cells.
Nuclear medicine and biology.
2013
Academic Article
GET IT
Times cited: 9 -
(18)F-labeled-bioorthogonal liposomes for in vivo targeting.
Bioconjugate chemistry.
2013
Academic Article
GET IT
Times cited: 72 -
Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter.
European journal of nuclear medicine and molecular imaging.
2013
Academic Article
GET IT
Times cited: 48 -
A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomy.
The Journal of urology.
2013
Academic Article
GET IT
Times cited: 67 -
Applying PET to broaden the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2013
Academic Article
GET IT
Times cited: 56 -
Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2013
Academic Article
GET IT
Times cited: 62 -
H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy.
Journal of the American Chemical Society.
2013
Academic Article
GET IT
Times cited: 71 -
Sandmeyer reaction repurposed for the site-selective, non-oxidizing radioiodination of fully-deprotected peptides: studies on the endogenous opioid peptide α-neoendorphin.
Bioorganic & medicinal chemistry letters.
2013
Academic Article
GET IT
Times cited: 8 -
Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome.
PloS one.
2013
Academic Article
GET IT
Times cited: 89 -
Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistry.
Bioconjugate chemistry.
2013
Academic Article
GET IT
Times cited: 122 -
A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2013
Academic Article
GET IT
Times cited: 229 -
The growing impact of bioorthogonal click chemistry on the development of radiopharmaceuticals.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2013
Information Resource
GET IT
Times cited: 111 -
Monitoring afatinib treatment in HER2-positive gastric cancer with 18F-FDG and 89Zr-trastuzumab PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2013
Academic Article
GET IT
Times cited: 88 -
Antilipolytic drug boosts glucose metabolism in prostate cancer.
Nuclear medicine and biology.
2013
Academic Article
GET IT
Times cited: 5 -
Imaging tumor burden in the brain with 89Zr-transferrin.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2012
Academic Article
GET IT
Times cited: 35 -
(89)Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer.
Pharmaceutical research.
2012
Academic Article
GET IT
Times cited: 83 -
H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu.
Inorganic chemistry.
2012
Academic Article
GET IT
Times cited: 48 -
Annotating MYC status with 89Zr-transferrin imaging.
Nature medicine.
2012
Academic Article
GET IT
Times cited: 77 -
PET imaging with ⁸⁹Zr: from radiochemistry to the clinic.
Nuclear medicine and biology.
2012
Information Resource
GET IT
Times cited: 320 -
Efficient (18)F-labeling of large 37-amino-acid pHLIP peptide analogues and their biological evaluation.
Bioconjugate chemistry.
2012
Academic Article
GET IT
Times cited: 59 -
An improved strategy for the synthesis of [¹⁸F]-labeled arabinofuranosyl nucleosides.
Nuclear medicine and biology.
2012
Academic Article
GET IT
Times cited: 12 -
Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.
Cancer discovery.
2012
Academic Article
GET IT
Times cited: 67 -
Dosimetry of 18F-labeled tyrosine kinase inhibitor SKI-249380, a dasatinib-tracer for PET imaging.
Molecular imaging and biology.
2012
Academic Article
GET IT
Times cited: 10 -
89Zr-labeled dextran nanoparticles allow in vivo macrophage imaging.
Bioconjugate chemistry.
2011
Academic Article
GET IT
Times cited: 124 -
Ex vivo sentinel lymph node mapping in laparoscopic resection of colon cancer.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
2011
Academic Article
GET IT
Times cited: 5 -
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90.
Nature chemical biology.
2011
Academic Article
GET IT
Times cited: 222 -
Modular strategy for the construction of radiometalated antibodies for positron emission tomography based on inverse electron demand Diels-Alder click chemistry.
Bioconjugate chemistry.
2011
Academic Article
GET IT
Times cited: 135 -
Targeting the internal epitope of prostate-specific membrane antigen with 89Zr-7E11 immuno-PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2011
Academic Article
GET IT
Times cited: 51 -
The next generation of positron emission tomography radiopharmaceuticals in oncology.
Seminars in nuclear medicine.
2011
Information Resource
GET IT
Times cited: 86 -
Intraoperative imaging of positron emission tomographic radiotracers using Cerenkov luminescence emissions.
Molecular imaging.
2011
Academic Article
GET IT
Times cited: 91 -
Magnitude of enhanced permeability and retention effect in tumors with different phenotypes: 89Zr-albumin as a model system.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2011
Academic Article
GET IT
Times cited: 137 -
Role of metalation in the topoisomerase IIα inhibition and antiproliferation activity of a series of α-heterocyclic-N4-substituted thiosemicarbazones and their Cu(II) complexes.
Journal of medicinal chemistry.
2011
Academic Article
GET IT
Times cited: 168 -
The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), a PET radiotracer designed for the delineation of histone deacetylase expression in cancer.
Nuclear medicine and biology.
2011
Academic Article
GET IT
Times cited: 15 -
Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes.
International journal of nanomedicine.
2010
Academic Article
GET IT
Times cited: 158 -
89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2010
Academic Article
GET IT
Times cited: 353 -
Cerenkov luminescence imaging of medical isotopes.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2010
Academic Article
GET IT
Times cited: 274 -
Improved synthesis of 2'-deoxy-2'-[18F]-fluoro-1-beta-D-arabinofuranosyl-5-iodouracil ([18F]-FIAU).
Nuclear medicine and biology.
2010
Academic Article
GET IT
Times cited: 28 -
Clickable bifunctional radiometal chelates for peptide labeling.
Chemical communications (Cambridge, England).
2010
Academic Article
GET IT
Times cited: 44 -
Unconventional nuclides for radiopharmaceuticals.
Molecular imaging.
2010
Information Resource
GET IT
Times cited: 134 -
Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab.
PloS one.
2010
Academic Article
GET IT
Times cited: 116 -
Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia.
Journal of inorganic biochemistry.
2009
Academic Article
GET IT
Times cited: 48 - Functionalised copper-64 complexes as precursors of potential PET imaging agents for neurodegenerative disorders. New Journal of Chemistry. 2009 Article GET IT
-
Standardized methods for the production of high specific-activity zirconium-89.
Nuclear medicine and biology.
2009
Academic Article
GET IT
Times cited: 347 -
A novel technology for the imaging of acidic prostate tumors by positron emission tomography.
Cancer research.
2009
Academic Article
GET IT
Times cited: 139 -
Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2009
Information Resource
GET IT
Times cited: 89 -
(64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity.
Nuclear medicine and biology.
2009
Academic Article
GET IT
Times cited: 87 -
Assessing tumor hypoxia by positron emission tomography with Cu-ATSM.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
2009
Information Resource
GET IT
Times cited: 79 -
Bromination from the macroscopic level to the tracer radiochemical level: (76)Br radiolabeling of aromatic compounds via electrophilic substitution.
Bioconjugate chemistry.
2009
Academic Article
GET IT
Times cited: 14 -
Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH.
Nuclear medicine and biology.
2009
Academic Article
GET IT
Times cited: 52 -
In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2009
Academic Article
GET IT
Times cited: 67 -
Synthesis and characterization of the copper(II) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the (64)Cu complexes.
Dalton transactions (Cambridge, England : 2003).
2008
Academic Article
GET IT
Times cited: 13 -
Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study.
Diseases of the colon and rectum.
2008
Academic Article
GET IT
Times cited: 158 -
Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer.
Nuclear medicine and biology.
2008
Academic Article
GET IT
Times cited: 75 -
Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies.
Nuclear medicine and biology.
2008
Academic Article
GET IT
Times cited: 16 -
An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2008
Academic Article
GET IT
Times cited: 170 -
In vitro and in vivo evaluation of bifunctional bisthiosemicarbazone 64Cu-complexes for the positron emission tomography imaging of hypoxia.
Journal of medicinal chemistry.
2008
Academic Article
GET IT
Times cited: 74 -
Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines.
Nuclear medicine and biology.
2008
Academic Article
GET IT
Times cited: 51 -
1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2008
Academic Article
GET IT
Times cited: 121 -
Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone).
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2008
Academic Article
GET IT
Times cited: 178 -
Synthesis, in vitro and in vivo characterization of (64)Cu(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligands.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry.
2007
Academic Article
GET IT
Times cited: 44 -
Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma.
Nuclear medicine and biology.
2007
Academic Article
GET IT
Times cited: 51 -
Diagnostic and prognostic value of ambulatory ECG (Holter) monitoring in patients with coronary heart disease: a review.
Journal of thrombosis and thrombolysis.
2007
Information Resource
GET IT
Times cited: 21 -
Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14).
Bioconjugate chemistry.
2007
Academic Article
GET IT
Times cited: 63 -
An anatomical study of tibial metaphyseal/diaphyseal mismatch during revision total knee arthroplasty.
The Journal of arthroplasty.
2007
Academic Article
GET IT
Times cited: 18 -
In vivo imaging in a murine model of glioblastoma.
Neurosurgery.
2007
Academic Article
GET IT
Times cited: 31 -
Production of non-standard PET radionuclides and the application of radiopharmaceuticals labeled with these nuclides.
Ernst Schering Research Foundation workshop.
2007
Information Resource
GET IT
Times cited: 15 -
Radiometal-labeled somatostatin analogs for applications in cancer imaging and therapy.
Methods in molecular biology (Clifton, N.J.).
2007
Information Resource
GET IT
Times cited: 18 -
Synthesis and biologic evaluation of 64Cu-labeled rhenium-cyclized alpha-MSH peptide analog using a cross-bridged cyclam chelator.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2007
Academic Article
GET IT
Times cited: 67 -
64Cu-azabicyclo[3.2.2]nonane thiosemicarbazone complexes: radiopharmaceuticals for PET of topoisomerase II expression in tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2006
Academic Article
GET IT
Times cited: 28 -
NuMA influences higher order chromatin organization in human mammary epithelium.
Molecular biology of the cell.
2006
Academic Article
GET IT
Times cited: 57 -
Imaging oxygenation of human tumours.
European radiology.
2006
Information Resource
GET IT
Times cited: 280 -
Validation of a novel CHX-A'' derivative suitable for peptide conjugation: small animal PET/CT imaging using yttrium-86-CHX-A''-octreotide.
Journal of medicinal chemistry.
2006
Academic Article
GET IT
Times cited: 43 -
Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2006
Academic Article
GET IT
Times cited: 29 -
In vivo skeletal imaging of 18F-fluoride with positron emission tomography reveals damage- and time-dependent responses to fatigue loading in the rat ulna.
Bone.
2006
Academic Article
GET IT
Times cited: 40 -
Assessment of myocardial blood flow using 15O-water and 1-11C-acetate in rats with small-animal PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2006
Academic Article
GET IT
Times cited: 42 -
Minimally invasive method of determining blood input function from PET images in rodents.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2006
Academic Article
GET IT
Times cited: 69 -
Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides.
Nuclear medicine and biology.
2006
Academic Article
GET IT
Times cited: 32 -
Preparation of high specific activity (86)Y using a small biomedical cyclotron.
Nuclear medicine and biology.
2005
Academic Article
GET IT
Times cited: 76 -
Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer.
Cancer research.
2005
Academic Article
GET IT
Times cited: 38 -
Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM.
Nuclear medicine and biology.
2005
Academic Article
GET IT
Times cited: 85 -
A tat fusion protein-based tumor vaccine for breast cancer.
Annals of surgical oncology.
2005
Academic Article
GET IT
Times cited: 26 -
Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH.
Journal of medicinal chemistry.
2005
Academic Article
GET IT
Times cited: 118 -
Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.
International journal of radiation oncology, biology, physics.
2005
Academic Article
GET IT
Times cited: 153 -
Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET.
European journal of nuclear medicine and molecular imaging.
2005
Academic Article
GET IT
Times cited: 71 -
Investigation into 64Cu-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agents.
Nuclear medicine and biology.
2005
Academic Article
GET IT
Times cited: 63 -
Basic characterization of 64Cu-ATSM as a radiotherapy agent.
Nuclear medicine and biology.
2005
Academic Article
GET IT
Times cited: 78 -
Positron-emitting isotopes produced on biomedical cyclotrons.
Current medicinal chemistry.
2005
Information Resource
GET IT
Times cited: 47 -
Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals.
Nuclear medicine and biology.
2003
Academic Article
GET IT
Times cited: 105 -
Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
Cancer research.
2003
Academic Article
GET IT
Times cited: 52 -
Imaging the effects of anti-angiogenic treatments.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR).
2003
Information Resource
GET IT
Times cited: 4 -
[Tc(CO)(3)](+) chemistry: a promising new concept for SPECT? Against.
European journal of nuclear medicine and molecular imaging.
2003
Academic Article
GET IT
Times cited: 12 -
Intra-tumoral distribution of (64)Cu-ATSM: a comparison study with FDG.
Nuclear medicine and biology.
2003
Academic Article
GET IT
Times cited: 50 -
Polyclonal antibodies to xenogeneic endothelial cells induce apoptosis and block support of tumor growth in mice.
Vaccine.
2003
Academic Article
GET IT
Times cited: 13 -
In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM.
European journal of nuclear medicine and molecular imaging.
2003
Academic Article
GET IT
Times cited: 313 -
Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.
International journal of radiation oncology, biology, physics.
2003
Academic Article
GET IT
Times cited: 294 -
Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone).
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2002
Academic Article
GET IT
Times cited: 75 - DOTA-D-Tyrl-octreotate: A somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy. Bioconjugate Chemistry. 2002 Article GET IT
-
Copper-64-pyruvaldehyde-bis(N(4)-methylthiosemicarbazone) for the prevention of tumor growth at wound sites following laparoscopic surgery: monitoring therapy response with microPET and magnetic resonance imaging.
Cancer research.
2002
Academic Article
GET IT
Times cited: 39 -
Toxicity and dosimetry of (177)Lu-DOTA-Y3-octreotate in a rat model.
International journal of cancer.
2001
Academic Article
GET IT
Times cited: 49 -
Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry.
2001
Academic Article
GET IT
Times cited: 224 -
Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2001
Academic Article
GET IT
Times cited: 183 -
A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy.
International journal of radiation oncology, biology, physics.
2001
Academic Article
GET IT
Times cited: 351 -
64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2001
Academic Article
GET IT
Times cited: 256 -
Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy.
Proceedings of the National Academy of Sciences of the United States of America.
2001
Academic Article
GET IT
Times cited: 209 -
Comparative dosimetry of copper-64 and yttrium-90-labeled somatostatin analogs in a tumor-bearing rat model.
Cancer biotherapy & radiopharmaceuticals.
2000
Academic Article
GET IT
Times cited: 28 -
Copper bis(diphosphine) complexes: radiopharmaceuticals for the detection of multi-drug resistance in tumours by PET.
European journal of nuclear medicine.
2000
Academic Article
GET IT
Times cited: 37 -
Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model.
Clinical cancer research : an official journal of the American Association for Cancer Research.
1999
Academic Article
GET IT
Times cited: 98 -
High purity production and potential applications of copper-60 and copper-61.
Nuclear medicine and biology.
1999
Academic Article
GET IT
Times cited: 130 -
Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy.
Journal of medicinal chemistry.
1999
Academic Article
GET IT
Times cited: 97 - Utilization of metabolic, transport and receptor-mediated processes to deliver agents for cancer diagnosis. Advanced drug delivery reviews. 1999 Academic Article GET IT
-
In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake.
Nuclear medicine and biology.
1999
Academic Article
GET IT
Times cited: 89 - Metal complexes as diagnostic tools. Coordination Chemistry Reviews. 1999 Article
-
Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
1999
Academic Article
GET IT
Times cited: 300 -
Effect of ligand and solvent on chloride ion coordination in anti-tumour copper(I) diphosphine complexes: Synthesis of [Cu(dppe)
2 ]Cl and analogous complexes (dppe = 1,2-bis(diphenylphosphino)ethane). Polyhedron. 1998 Article - Redox-active metal complexes for imaging hypoxic tissues: Structure-activity relationships in copper(II) bis(thiosemicarbazone) complexes. Chemical Communications. 1998 Article
-
Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
1998
Academic Article
GET IT
Times cited: 135 -
Design of hypoxia-targeting radiopharmaceuticals: selective uptake of copper-64 complexes in hypoxic cells in vitro.
European journal of nuclear medicine.
1998
Academic Article
GET IT
Times cited: 105 -
Diphosphine bifunctional chelators for low-valent metal ions. Crystal structures of the copper(I) complexes [CuClL1
2 ] and [CuL12 ][PF6 ] [L1 = 2,3-bis(diphenylphosphino)maleic anhydride]. Journal of the Chemical Society - Dalton Transactions. 1997 Article - Complexes of potentially tri- and tetra-dentate phosphinothiol ligands with Mo, W, Re, Fe, Ru, Os, Rh, Ir and Ni. Journal of the Chemical Society - Dalton Transactions. 1996 Article
- Copper(I) bis(diphosphine) complexes as a basis for radiopharmaceuticals for positron emission tomography and targeted radiotherapy. Chemical Communications. 1996 Article
-
Rhenium complex of a triply deprotonated chelated thiosemicarbazide and its conversion to a nitride complex via a hydrazide intermediate. Crystal structure of [ReCl
2 (NH)(NHNH2 )(PPh3 )2 ]. Journal of the Chemical Society, Dalton Transactions. 1995 Article GET IT -
The preparation of rhenium(V) oxo and imido complexes with Et
2 NCSNHCOPh and Et2 NCSBC(NH)Ph. The x-ray crystal structure of [ReOCl(PhCONCSNEt2 )2 ]. Polyhedron. 1993 Article GET IT -
Abnormal skeletal response to parathyroid hormone in dogs with chronic uremia.
Calcified tissue international.
1982
Academic Article
GET IT
Times cited: 22 -
Dissociation of renal cyclic AMP and phosphate responses to parathyroid hormone in uremia.
Calcified tissue international.
1979
Academic Article
GET IT
Times cited: 1 - The C-O binary combination spectra of some pentacarbonyl metal complexes. Journal of the Chemical Society A: Inorganic, Physical, Theoretical. 1968 Article GET IT
- 1098. The infrared spectra of some addition compounds of aluminium and gallium trihalides. Journal of the Chemical Society (Resumed). 1965 Article GET IT